hel ova Search Results


90
Biozyme Laboratories ova and hel conjugate
P. chabaudi infection causes reduced expansion of B cells and failure of CD4 + T-cell migration through modulation of DCs. (a) Uninfected (squares) or P. chabaudi -infected (circles) BALB/c mice <t>received</t> <t>OVA-specific</t> CD4 + T cells and <t>HEL-specific</t> B cells 12 days after infection and were immunized with OVA-HEL/LPS (filled symbols) 24 h later. Controls remained unimmunized (open symbols). Results shown are the absolute number of HEL-specific B cells in the spleen (left) and lymph nodes (LN, right) and represent the mean of 3 mice per group ±1 s.d. and are representative of 3 similar experiments (* p ≤ 0.05, # p ≤ 0.005 uninfected and immunized versus P. chabaudi -infected immunized). (b) Five days after immunization, spleens from the mice described in (a) were snap frozen and prepared for immunohistochemistry. Sections were stained using biotinylated-KJ1.26 followed by Streptavidin-AlexaFluor 647 to detect OVA-specific T cells (red) and B220-FITC to identify B-cell areas (green). Images shown are representative of 3 mice per group from 2 similar experiments. (c) Sections stained as in (b) were analyzed by laser-scanning cytometry. Results are expressed as mean proportion of OVA-specific T cells per unit area in the regions indicated. The number of OVA-specific T cells contained in identically sized regions of follicle and periarteriolar lymphoid sheath (PALS) was calculated and expressed as a proportion of total KJ1.26 + cells in the section to avoid bias due to the difference in expansion between uninfected and infected spleens. Results represent triplicate readings of 3 mice per group ±1 s.d. (* p ≤ 0.05 uninfected and immunized versus P. chabaudi -infected and immunized). (d) Bone-marrow-derived DCs were cultured with P. chabaudi pRBCs (circles) or RBCs (squares) for 18 h before pulsing with 5 mg/ml OVA (filled symbols). Controls remained unpulsed (open symbols). OVA-specific CD4 + T cells were then added at a ratio of 1:1 and cultured for 72 h in vitro . T cells were isolated, washed and transferred into uninfected recipients immunized 48 h before transfer to synchronize the immune response. Clonal expansion was then assessed as described above. Results show the mean proportion of CD4 + KJ1.26 + T cells and represent the mean of 3 mice per group ±1 s.d. (* p ≤ 0.05, RBC-cultured, OVA-pulsed DCs versus pRBC-cultured, OVA-pulsed DC). (e) DCs were purified from spleens of uninfected or P. chabaudi -infected mice and pulsed with 5 mg/ml OVA for 2 h. Cells were then harvested, washed and 5 × 10 5 DCs transferred into uninfected BALB/c mice along with CFSE-labeled OVA-specific T cells. The level of CFSE in OVA-specific CD4 + cells was analyzed 5 days later, as described in Figure 8.
Ova And Hel Conjugate, supplied by Biozyme Laboratories, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/ova and hel conjugate/product/Biozyme Laboratories
Average 90 stars, based on 1 article reviews
ova and hel conjugate - by Bioz Stars, 2026-04
90/100 stars
  Buy from Supplier

90
Brenntag Inc chicken ova-hel
P. chabaudi infection causes reduced expansion of B cells and failure of CD4 + T-cell migration through modulation of DCs. (a) Uninfected (squares) or P. chabaudi -infected (circles) BALB/c mice <t>received</t> <t>OVA-specific</t> CD4 + T cells and <t>HEL-specific</t> B cells 12 days after infection and were immunized with OVA-HEL/LPS (filled symbols) 24 h later. Controls remained unimmunized (open symbols). Results shown are the absolute number of HEL-specific B cells in the spleen (left) and lymph nodes (LN, right) and represent the mean of 3 mice per group ±1 s.d. and are representative of 3 similar experiments (* p ≤ 0.05, # p ≤ 0.005 uninfected and immunized versus P. chabaudi -infected immunized). (b) Five days after immunization, spleens from the mice described in (a) were snap frozen and prepared for immunohistochemistry. Sections were stained using biotinylated-KJ1.26 followed by Streptavidin-AlexaFluor 647 to detect OVA-specific T cells (red) and B220-FITC to identify B-cell areas (green). Images shown are representative of 3 mice per group from 2 similar experiments. (c) Sections stained as in (b) were analyzed by laser-scanning cytometry. Results are expressed as mean proportion of OVA-specific T cells per unit area in the regions indicated. The number of OVA-specific T cells contained in identically sized regions of follicle and periarteriolar lymphoid sheath (PALS) was calculated and expressed as a proportion of total KJ1.26 + cells in the section to avoid bias due to the difference in expansion between uninfected and infected spleens. Results represent triplicate readings of 3 mice per group ±1 s.d. (* p ≤ 0.05 uninfected and immunized versus P. chabaudi -infected and immunized). (d) Bone-marrow-derived DCs were cultured with P. chabaudi pRBCs (circles) or RBCs (squares) for 18 h before pulsing with 5 mg/ml OVA (filled symbols). Controls remained unpulsed (open symbols). OVA-specific CD4 + T cells were then added at a ratio of 1:1 and cultured for 72 h in vitro . T cells were isolated, washed and transferred into uninfected recipients immunized 48 h before transfer to synchronize the immune response. Clonal expansion was then assessed as described above. Results show the mean proportion of CD4 + KJ1.26 + T cells and represent the mean of 3 mice per group ±1 s.d. (* p ≤ 0.05, RBC-cultured, OVA-pulsed DCs versus pRBC-cultured, OVA-pulsed DC). (e) DCs were purified from spleens of uninfected or P. chabaudi -infected mice and pulsed with 5 mg/ml OVA for 2 h. Cells were then harvested, washed and 5 × 10 5 DCs transferred into uninfected BALB/c mice along with CFSE-labeled OVA-specific T cells. The level of CFSE in OVA-specific CD4 + cells was analyzed 5 days later, as described in Figure 8.
Chicken Ova Hel, supplied by Brenntag Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/chicken ova-hel/product/Brenntag Inc
Average 90 stars, based on 1 article reviews
chicken ova-hel - by Bioz Stars, 2026-04
90/100 stars
  Buy from Supplier

90
Verlag GmbH ova-hel protein
P. chabaudi infection causes reduced expansion of B cells and failure of CD4 + T-cell migration through modulation of DCs. (a) Uninfected (squares) or P. chabaudi -infected (circles) BALB/c mice <t>received</t> <t>OVA-specific</t> CD4 + T cells and <t>HEL-specific</t> B cells 12 days after infection and were immunized with OVA-HEL/LPS (filled symbols) 24 h later. Controls remained unimmunized (open symbols). Results shown are the absolute number of HEL-specific B cells in the spleen (left) and lymph nodes (LN, right) and represent the mean of 3 mice per group ±1 s.d. and are representative of 3 similar experiments (* p ≤ 0.05, # p ≤ 0.005 uninfected and immunized versus P. chabaudi -infected immunized). (b) Five days after immunization, spleens from the mice described in (a) were snap frozen and prepared for immunohistochemistry. Sections were stained using biotinylated-KJ1.26 followed by Streptavidin-AlexaFluor 647 to detect OVA-specific T cells (red) and B220-FITC to identify B-cell areas (green). Images shown are representative of 3 mice per group from 2 similar experiments. (c) Sections stained as in (b) were analyzed by laser-scanning cytometry. Results are expressed as mean proportion of OVA-specific T cells per unit area in the regions indicated. The number of OVA-specific T cells contained in identically sized regions of follicle and periarteriolar lymphoid sheath (PALS) was calculated and expressed as a proportion of total KJ1.26 + cells in the section to avoid bias due to the difference in expansion between uninfected and infected spleens. Results represent triplicate readings of 3 mice per group ±1 s.d. (* p ≤ 0.05 uninfected and immunized versus P. chabaudi -infected and immunized). (d) Bone-marrow-derived DCs were cultured with P. chabaudi pRBCs (circles) or RBCs (squares) for 18 h before pulsing with 5 mg/ml OVA (filled symbols). Controls remained unpulsed (open symbols). OVA-specific CD4 + T cells were then added at a ratio of 1:1 and cultured for 72 h in vitro . T cells were isolated, washed and transferred into uninfected recipients immunized 48 h before transfer to synchronize the immune response. Clonal expansion was then assessed as described above. Results show the mean proportion of CD4 + KJ1.26 + T cells and represent the mean of 3 mice per group ±1 s.d. (* p ≤ 0.05, RBC-cultured, OVA-pulsed DCs versus pRBC-cultured, OVA-pulsed DC). (e) DCs were purified from spleens of uninfected or P. chabaudi -infected mice and pulsed with 5 mg/ml OVA for 2 h. Cells were then harvested, washed and 5 × 10 5 DCs transferred into uninfected BALB/c mice along with CFSE-labeled OVA-specific T cells. The level of CFSE in OVA-specific CD4 + cells was analyzed 5 days later, as described in Figure 8.
Ova Hel Protein, supplied by Verlag GmbH, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/ova-hel protein/product/Verlag GmbH
Average 90 stars, based on 1 article reviews
ova-hel protein - by Bioz Stars, 2026-04
90/100 stars
  Buy from Supplier

90
Solulink Inc hel-ova conjugate antigen
P. chabaudi infection causes reduced expansion of B cells and failure of CD4 + T-cell migration through modulation of DCs. (a) Uninfected (squares) or P. chabaudi -infected (circles) BALB/c mice <t>received</t> <t>OVA-specific</t> CD4 + T cells and <t>HEL-specific</t> B cells 12 days after infection and were immunized with OVA-HEL/LPS (filled symbols) 24 h later. Controls remained unimmunized (open symbols). Results shown are the absolute number of HEL-specific B cells in the spleen (left) and lymph nodes (LN, right) and represent the mean of 3 mice per group ±1 s.d. and are representative of 3 similar experiments (* p ≤ 0.05, # p ≤ 0.005 uninfected and immunized versus P. chabaudi -infected immunized). (b) Five days after immunization, spleens from the mice described in (a) were snap frozen and prepared for immunohistochemistry. Sections were stained using biotinylated-KJ1.26 followed by Streptavidin-AlexaFluor 647 to detect OVA-specific T cells (red) and B220-FITC to identify B-cell areas (green). Images shown are representative of 3 mice per group from 2 similar experiments. (c) Sections stained as in (b) were analyzed by laser-scanning cytometry. Results are expressed as mean proportion of OVA-specific T cells per unit area in the regions indicated. The number of OVA-specific T cells contained in identically sized regions of follicle and periarteriolar lymphoid sheath (PALS) was calculated and expressed as a proportion of total KJ1.26 + cells in the section to avoid bias due to the difference in expansion between uninfected and infected spleens. Results represent triplicate readings of 3 mice per group ±1 s.d. (* p ≤ 0.05 uninfected and immunized versus P. chabaudi -infected and immunized). (d) Bone-marrow-derived DCs were cultured with P. chabaudi pRBCs (circles) or RBCs (squares) for 18 h before pulsing with 5 mg/ml OVA (filled symbols). Controls remained unpulsed (open symbols). OVA-specific CD4 + T cells were then added at a ratio of 1:1 and cultured for 72 h in vitro . T cells were isolated, washed and transferred into uninfected recipients immunized 48 h before transfer to synchronize the immune response. Clonal expansion was then assessed as described above. Results show the mean proportion of CD4 + KJ1.26 + T cells and represent the mean of 3 mice per group ±1 s.d. (* p ≤ 0.05, RBC-cultured, OVA-pulsed DCs versus pRBC-cultured, OVA-pulsed DC). (e) DCs were purified from spleens of uninfected or P. chabaudi -infected mice and pulsed with 5 mg/ml OVA for 2 h. Cells were then harvested, washed and 5 × 10 5 DCs transferred into uninfected BALB/c mice along with CFSE-labeled OVA-specific T cells. The level of CFSE in OVA-specific CD4 + cells was analyzed 5 days later, as described in Figure 8.
Hel Ova Conjugate Antigen, supplied by Solulink Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/hel-ova conjugate antigen/product/Solulink Inc
Average 90 stars, based on 1 article reviews
hel-ova conjugate antigen - by Bioz Stars, 2026-04
90/100 stars
  Buy from Supplier

90
Solulink Inc hel-ova conjugate ag
P. chabaudi infection causes reduced expansion of B cells and failure of CD4 + T-cell migration through modulation of DCs. (a) Uninfected (squares) or P. chabaudi -infected (circles) BALB/c mice <t>received</t> <t>OVA-specific</t> CD4 + T cells and <t>HEL-specific</t> B cells 12 days after infection and were immunized with OVA-HEL/LPS (filled symbols) 24 h later. Controls remained unimmunized (open symbols). Results shown are the absolute number of HEL-specific B cells in the spleen (left) and lymph nodes (LN, right) and represent the mean of 3 mice per group ±1 s.d. and are representative of 3 similar experiments (* p ≤ 0.05, # p ≤ 0.005 uninfected and immunized versus P. chabaudi -infected immunized). (b) Five days after immunization, spleens from the mice described in (a) were snap frozen and prepared for immunohistochemistry. Sections were stained using biotinylated-KJ1.26 followed by Streptavidin-AlexaFluor 647 to detect OVA-specific T cells (red) and B220-FITC to identify B-cell areas (green). Images shown are representative of 3 mice per group from 2 similar experiments. (c) Sections stained as in (b) were analyzed by laser-scanning cytometry. Results are expressed as mean proportion of OVA-specific T cells per unit area in the regions indicated. The number of OVA-specific T cells contained in identically sized regions of follicle and periarteriolar lymphoid sheath (PALS) was calculated and expressed as a proportion of total KJ1.26 + cells in the section to avoid bias due to the difference in expansion between uninfected and infected spleens. Results represent triplicate readings of 3 mice per group ±1 s.d. (* p ≤ 0.05 uninfected and immunized versus P. chabaudi -infected and immunized). (d) Bone-marrow-derived DCs were cultured with P. chabaudi pRBCs (circles) or RBCs (squares) for 18 h before pulsing with 5 mg/ml OVA (filled symbols). Controls remained unpulsed (open symbols). OVA-specific CD4 + T cells were then added at a ratio of 1:1 and cultured for 72 h in vitro . T cells were isolated, washed and transferred into uninfected recipients immunized 48 h before transfer to synchronize the immune response. Clonal expansion was then assessed as described above. Results show the mean proportion of CD4 + KJ1.26 + T cells and represent the mean of 3 mice per group ±1 s.d. (* p ≤ 0.05, RBC-cultured, OVA-pulsed DCs versus pRBC-cultured, OVA-pulsed DC). (e) DCs were purified from spleens of uninfected or P. chabaudi -infected mice and pulsed with 5 mg/ml OVA for 2 h. Cells were then harvested, washed and 5 × 10 5 DCs transferred into uninfected BALB/c mice along with CFSE-labeled OVA-specific T cells. The level of CFSE in OVA-specific CD4 + cells was analyzed 5 days later, as described in Figure 8.
Hel Ova Conjugate Ag, supplied by Solulink Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/hel-ova conjugate ag/product/Solulink Inc
Average 90 stars, based on 1 article reviews
hel-ova conjugate ag - by Bioz Stars, 2026-04
90/100 stars
  Buy from Supplier

90
Brenntag Inc ova-hel in 1% alum
P. chabaudi infection causes reduced expansion of B cells and failure of CD4 + T-cell migration through modulation of DCs. (a) Uninfected (squares) or P. chabaudi -infected (circles) BALB/c mice <t>received</t> <t>OVA-specific</t> CD4 + T cells and <t>HEL-specific</t> B cells 12 days after infection and were immunized with OVA-HEL/LPS (filled symbols) 24 h later. Controls remained unimmunized (open symbols). Results shown are the absolute number of HEL-specific B cells in the spleen (left) and lymph nodes (LN, right) and represent the mean of 3 mice per group ±1 s.d. and are representative of 3 similar experiments (* p ≤ 0.05, # p ≤ 0.005 uninfected and immunized versus P. chabaudi -infected immunized). (b) Five days after immunization, spleens from the mice described in (a) were snap frozen and prepared for immunohistochemistry. Sections were stained using biotinylated-KJ1.26 followed by Streptavidin-AlexaFluor 647 to detect OVA-specific T cells (red) and B220-FITC to identify B-cell areas (green). Images shown are representative of 3 mice per group from 2 similar experiments. (c) Sections stained as in (b) were analyzed by laser-scanning cytometry. Results are expressed as mean proportion of OVA-specific T cells per unit area in the regions indicated. The number of OVA-specific T cells contained in identically sized regions of follicle and periarteriolar lymphoid sheath (PALS) was calculated and expressed as a proportion of total KJ1.26 + cells in the section to avoid bias due to the difference in expansion between uninfected and infected spleens. Results represent triplicate readings of 3 mice per group ±1 s.d. (* p ≤ 0.05 uninfected and immunized versus P. chabaudi -infected and immunized). (d) Bone-marrow-derived DCs were cultured with P. chabaudi pRBCs (circles) or RBCs (squares) for 18 h before pulsing with 5 mg/ml OVA (filled symbols). Controls remained unpulsed (open symbols). OVA-specific CD4 + T cells were then added at a ratio of 1:1 and cultured for 72 h in vitro . T cells were isolated, washed and transferred into uninfected recipients immunized 48 h before transfer to synchronize the immune response. Clonal expansion was then assessed as described above. Results show the mean proportion of CD4 + KJ1.26 + T cells and represent the mean of 3 mice per group ±1 s.d. (* p ≤ 0.05, RBC-cultured, OVA-pulsed DCs versus pRBC-cultured, OVA-pulsed DC). (e) DCs were purified from spleens of uninfected or P. chabaudi -infected mice and pulsed with 5 mg/ml OVA for 2 h. Cells were then harvested, washed and 5 × 10 5 DCs transferred into uninfected BALB/c mice along with CFSE-labeled OVA-specific T cells. The level of CFSE in OVA-specific CD4 + cells was analyzed 5 days later, as described in Figure 8.
Ova Hel In 1% Alum, supplied by Brenntag Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/ova-hel in 1% alum/product/Brenntag Inc
Average 90 stars, based on 1 article reviews
ova-hel in 1% alum - by Bioz Stars, 2026-04
90/100 stars
  Buy from Supplier

Image Search Results


P. chabaudi infection causes reduced expansion of B cells and failure of CD4 + T-cell migration through modulation of DCs. (a) Uninfected (squares) or P. chabaudi -infected (circles) BALB/c mice received OVA-specific CD4 + T cells and HEL-specific B cells 12 days after infection and were immunized with OVA-HEL/LPS (filled symbols) 24 h later. Controls remained unimmunized (open symbols). Results shown are the absolute number of HEL-specific B cells in the spleen (left) and lymph nodes (LN, right) and represent the mean of 3 mice per group ±1 s.d. and are representative of 3 similar experiments (* p ≤ 0.05, # p ≤ 0.005 uninfected and immunized versus P. chabaudi -infected immunized). (b) Five days after immunization, spleens from the mice described in (a) were snap frozen and prepared for immunohistochemistry. Sections were stained using biotinylated-KJ1.26 followed by Streptavidin-AlexaFluor 647 to detect OVA-specific T cells (red) and B220-FITC to identify B-cell areas (green). Images shown are representative of 3 mice per group from 2 similar experiments. (c) Sections stained as in (b) were analyzed by laser-scanning cytometry. Results are expressed as mean proportion of OVA-specific T cells per unit area in the regions indicated. The number of OVA-specific T cells contained in identically sized regions of follicle and periarteriolar lymphoid sheath (PALS) was calculated and expressed as a proportion of total KJ1.26 + cells in the section to avoid bias due to the difference in expansion between uninfected and infected spleens. Results represent triplicate readings of 3 mice per group ±1 s.d. (* p ≤ 0.05 uninfected and immunized versus P. chabaudi -infected and immunized). (d) Bone-marrow-derived DCs were cultured with P. chabaudi pRBCs (circles) or RBCs (squares) for 18 h before pulsing with 5 mg/ml OVA (filled symbols). Controls remained unpulsed (open symbols). OVA-specific CD4 + T cells were then added at a ratio of 1:1 and cultured for 72 h in vitro . T cells were isolated, washed and transferred into uninfected recipients immunized 48 h before transfer to synchronize the immune response. Clonal expansion was then assessed as described above. Results show the mean proportion of CD4 + KJ1.26 + T cells and represent the mean of 3 mice per group ±1 s.d. (* p ≤ 0.05, RBC-cultured, OVA-pulsed DCs versus pRBC-cultured, OVA-pulsed DC). (e) DCs were purified from spleens of uninfected or P. chabaudi -infected mice and pulsed with 5 mg/ml OVA for 2 h. Cells were then harvested, washed and 5 × 10 5 DCs transferred into uninfected BALB/c mice along with CFSE-labeled OVA-specific T cells. The level of CFSE in OVA-specific CD4 + cells was analyzed 5 days later, as described in Figure 8.

Journal: Journal of Biology

Article Title: Suppression of adaptive immunity to heterologous antigens during Plasmodium infection through hemozoin-induced failure of dendritic cell function

doi: 10.1186/jbiol34

Figure Lengend Snippet: P. chabaudi infection causes reduced expansion of B cells and failure of CD4 + T-cell migration through modulation of DCs. (a) Uninfected (squares) or P. chabaudi -infected (circles) BALB/c mice received OVA-specific CD4 + T cells and HEL-specific B cells 12 days after infection and were immunized with OVA-HEL/LPS (filled symbols) 24 h later. Controls remained unimmunized (open symbols). Results shown are the absolute number of HEL-specific B cells in the spleen (left) and lymph nodes (LN, right) and represent the mean of 3 mice per group ±1 s.d. and are representative of 3 similar experiments (* p ≤ 0.05, # p ≤ 0.005 uninfected and immunized versus P. chabaudi -infected immunized). (b) Five days after immunization, spleens from the mice described in (a) were snap frozen and prepared for immunohistochemistry. Sections were stained using biotinylated-KJ1.26 followed by Streptavidin-AlexaFluor 647 to detect OVA-specific T cells (red) and B220-FITC to identify B-cell areas (green). Images shown are representative of 3 mice per group from 2 similar experiments. (c) Sections stained as in (b) were analyzed by laser-scanning cytometry. Results are expressed as mean proportion of OVA-specific T cells per unit area in the regions indicated. The number of OVA-specific T cells contained in identically sized regions of follicle and periarteriolar lymphoid sheath (PALS) was calculated and expressed as a proportion of total KJ1.26 + cells in the section to avoid bias due to the difference in expansion between uninfected and infected spleens. Results represent triplicate readings of 3 mice per group ±1 s.d. (* p ≤ 0.05 uninfected and immunized versus P. chabaudi -infected and immunized). (d) Bone-marrow-derived DCs were cultured with P. chabaudi pRBCs (circles) or RBCs (squares) for 18 h before pulsing with 5 mg/ml OVA (filled symbols). Controls remained unpulsed (open symbols). OVA-specific CD4 + T cells were then added at a ratio of 1:1 and cultured for 72 h in vitro . T cells were isolated, washed and transferred into uninfected recipients immunized 48 h before transfer to synchronize the immune response. Clonal expansion was then assessed as described above. Results show the mean proportion of CD4 + KJ1.26 + T cells and represent the mean of 3 mice per group ±1 s.d. (* p ≤ 0.05, RBC-cultured, OVA-pulsed DCs versus pRBC-cultured, OVA-pulsed DC). (e) DCs were purified from spleens of uninfected or P. chabaudi -infected mice and pulsed with 5 mg/ml OVA for 2 h. Cells were then harvested, washed and 5 × 10 5 DCs transferred into uninfected BALB/c mice along with CFSE-labeled OVA-specific T cells. The level of CFSE in OVA-specific CD4 + cells was analyzed 5 days later, as described in Figure 8.

Article Snippet: At various times following malaria infection, mice were immunized intravenously with 500 μg OVA (Sigma-Aldrich, Poole, UK), or a conjugate of OVA and HEL (Biozyme, Gwent, UK) [ ], along with 50 ng LPS (from Salmonella equi-abortus ; Sigma-Aldrich).

Techniques: Infection, Migration, Immunohistochemistry, Staining, Cytometry, Derivative Assay, Cell Culture, In Vitro, Isolation, Purification, Labeling